Ropivacaine hydrochloride monohydrate , ≥98%(HPLC) , 132112-35-7
Synonym(s):
(2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide hydrochloride monohydrate;(S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate;Naropin hydrochloride monohydrate;Ropivacaine hydrochloride monohydrate
CAS NO.:132112-35-7
Empirical Formula: C17H26N2O.ClH.H2O
Molecular Weight: 328.88
MDL number: MFCD02102164
EINECS: 663-286-1
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB23.20 | In Stock |
|
| 50MG | RMB31.20 | In Stock |
|
| 250MG | RMB39.20 | In Stock |
|
| 1g | RMB84.80 | In Stock |
|
| 5g | RMB272.80 | In Stock |
|
| 25g | RMB898.40 | In Stock |
|
| 100g | RMB1919.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 267-269°C |
| alpha | D20 -7.28° (c = 2 in water) |
| storage temp. | 2-8°C |
| solubility | H2O: soluble5mg/mL, clear |
| form | powder |
| color | white to off-white |
| optical activity | [α]/D -9 to -12, c = 1 in methanol |
| Water Solubility | H2O: 5mg/mL, clear |
| InChI | InChI=1/C17H26N2O.ClH.H2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H;1H2/t15-;;/s3 |
| InChIKey | VSHFRHVKMYGBJL-CKUXDGONSA-N |
| SMILES | [C@H]1(CCCCN1CCC)C(=O)NC1=C(C)C=CC=C1C.O.Cl |&1:0,r| |
| CAS DataBase Reference | 132112-35-7(CAS DataBase Reference) |
Description and Uses
(–)-Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. In vivo, (–)-ropivacaine induces complete impairment of proprioception, motor function, and nociception in the hindleg of rats when 100 μL of an 8 mM solution is injected percutaneously into the sciatic nerve. (–)-Ropivacaine depresses myocardial contractile force in isolated rat hearts less potently than (±)-ropivacaine, as well as (–)- and (±)-bupivacaine . Formulations containing (–)-ropivacaine have been used as local anesthetics during surgery and childbirth.
Ropivacaine hydrochloride monohydrate has been used as an analyte in tandem mass spectrometry and as an amide-based local anaesthetic to test its effect on breast cancer cell methylation.
Safety
| Symbol(GHS) | ![]() GHS05 |
| Signal word | Danger |
| Hazard statements | H318 |
| Precautionary statements | P280-P305+P351+P338 |
| Hazard Codes | T,Xi |
| Risk Statements | 26/27/28-41 |
| Safety Statements | 22-36/37/39-45-39-26 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | 3 |
| HS Code | 2933399090 |





